EX-99.1 2 d784777dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

 

LOGO

FOR IMMEDIATE RELEASE

AMERICAN VANGUARD REPORTS SECOND QUARTER AND MID-YEAR 2019 RESULTS

Performance Affected By Unfavorable North American Weather

Newport Beach, CA – August 6, 2019 – American Vanguard Corporation (NYSE:AVD), today announced financial results for the quarter and half-year ended June 30, 2019.

Financial Highlights Fiscal 2019 Second Quarter – versus Fiscal 2018 Second Quarter

 

   

Net sales of $113 million in 2019, compared with $107 million in 2018

 

   

Net income of $3.1 million in 2019, compared with $5.6 million in 2018

 

   

Earnings per diluted share of $0.11 in 2019, compared with $0.19 in 2018

 

   

EBITDA1 of $11.9 million in 2019, compared with $14 million in 2018

Financial Highlights Fiscal 2019 First Six Months – versus Fiscal 2018 First Six Months

 

   

Net sales of $213 million in 2019, compared with $211 million in 2018

 

   

Net income of $7 million in 2019, compared with $10.25 million in 2018

 

   

Earnings per diluted share of $0.24 in 2019, compared with $0.34 in 2018

 

   

EBITDA of $24.5 million in 2019, compared to $27.3 million in 2018

Eric Wintemute, Chairman and CEO of American Vanguard commented, “Our overall financial performance in this year’s second quarter and first half was significantly affected by widespread unfavorable weather in the U.S. Persistent cold and rainfall had a negative influence on our U.S. crop business particularly in both the Midwest and Southeastern regions, where there were planting delays, several million unplanted acres and sluggish crop protection procurement. By contrast, both our domestic non-crop and international businesses posted double-digit growth allowing us to record a 6% quarterly net sales increase over the prior year.”

Mr. Wintemute continued, “Our second quarter gross profit margin was 37% (versus 40% in 2Q2018) as we began moderating manufacturing output in order to achieve significant second-half inventory reductions. As you may

 

1 

Earnings before interest, taxes, depreciation and amortization. EBITDA is not a financial measure calculated and presented in accordance with U.S. generally accepted accounting principles (GAAP) and should not be considered as an alternative to net income (loss), operating income (loss) or any other financial measure so calculated and presented, nor as an alternative to cash flow from operating activities as a measure of liquidity. The items excluded from EBITDA are detailed in the reconciliation attached to this news release. Other companies (including the Company’s competitors) may define EBITDA differently. The Company believes that the use of EBITDA is useful to investors in that it is one of the primary bases upon which borrowing capacity is calculated under the Company’s senior credit facility, it gives investors a sense of the Company’s financial conditions and results of operation without giving effect to the cost of increased acquisition activity and it is commonly used by investors and others as a basis for supporting overall business valuations. Nevertheless, investors should not consider EBITDA in isolation or a substitute for analysis of the Company’s results as reported in accordance with GAAP.


recall, recent inventory levels have been driven largely by both the need to stock products in newly acquired businesses and the expedited purchase of goods from China to minimize tariffs. We expect that through inventory reduction and operating performance during the second half, we will be able to reduce debt by $50 million by year end.”

Mr. Wintemute concluded, “As indicated in our earlier announcement, in the second half of the year, we expect solid performance from our soil fumigants, cotton harvest products and the Central and South American businesses. We reiterate our full-year 2019 guidance of approximately $500 million in net sales; gross profit margins around 38%; operating expenses near $155 million; interest expense at $8 million; and a comprehensive tax of 26%. Given the probable reduction of 2019 U.S. harvest results and reduced levels of our products in channel inventory, the domestic market may be poised for a rebound in 2020. We look forward to providing investors with additional information during our earning conference call.”

Conference Call

Eric Wintemute, Chairman & CEO, Bob Trogele EVP & COO and David T. Johnson, VP & CFO, will conduct a conference call focusing on the financial results at 4:30 pm ET / 1:30 pm PT on Tuesday, August 6, 2019. Interested parties may participate in the call by dialing (201) 493-6744 – please dial in 10 minutes before the call is scheduled to begin, and ask for the American Vanguard call. The conference call will also be webcast live via the News and Media section of the Company’s web site at www.american-vanguard.com. To listen to the live webcast, go to the web site at least 15 minutes early to register, download and install any necessary audio software. If you are unable to listen live, the conference call will be archived on the Company’s web site.

About American Vanguard

American Vanguard Corporation is a diversified specialty and agricultural products company that develops and markets products for crop protection and management, turf and ornamentals management and public and animal health. American Vanguard is included on the Russell 2000® and Russell 3000® Indexes and the Standard & Poor’s Small Cap 600 Index. To learn more about American Vanguard, please reference the Company’s web site at www.american-vanguard.com.

The Company, from time to time, may discuss forward-looking information. Except for the historical information contained in this release, all forward-looking statements are estimates by the Company’s management and are subject to various risks and uncertainties that may cause results to differ from management’s current expectations. Such factors include weather conditions, changes in regulatory policy and other risks as detailed from time-to-time in the Company’s SEC reports and filings. All forward-looking statements, if any, in this release represent the Company’s judgment as of the date of this release.    

 

Company Contact:    Investor Representative
American Vanguard Corporation    The Equity Group Inc.
William A. Kuser, Director of Investor Relations    www.theequitygroup.com
(949) 260-1200    Lena Cati (212) 836-9611
williamk@amvac-chemical.com    Lcati@equityny.com


AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)

(Unaudited)

 

ASSETS    June 30,
2019
    December 31,
2018
 

Current assets:

    

Cash and cash equivalents

   $ 6,307     $ 6,168  

Receivables:

    

Trade, net of allowance for doubtful accounts of $1,707 and $1,263, respectively

     118,351       123,320  

Other

     12,679       10,709  
  

 

 

   

 

 

 

Total receivables, net

     131,030       134,029  

Inventories, net

     193,393       159,895  

Prepaid expenses

     11,717       10,096  

Income taxes receivable

     445       —    
  

 

 

   

 

 

 

Total current assets

     342,892       310,188  

Property, plant and equipment, net

     53,637       49,252  

Operating lease right-of-use assets

     12,420       —    

Intangible assets, net of amortization

     194,337       186,583  

Goodwill

     39,436       25,790  

Other assets

     23,087       21,774  
  

 

 

   

 

 

 

Total assets

   $ 665,809     $ 593,587  
  

 

 

   

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

Current liabilities:

    

Current installments of other liabilities

   $ 1,320     $ 1,609  

Accounts payable

     62,220       66,535  

Deferred revenue

     751       20,043  

Accrued program costs

     49,172       37,349  

Accrued expenses and other payables

     11,085       15,962  

Operating lease liabilities, current

     4,749       —    

Income taxes payable

     —         4,030  
  

 

 

   

 

 

 

Total current liabilities

     129,297       145,528  

Long-term debt, net of deferred loan fees

     164,574       96,671  

Operating lease liabilities, long-term

     7,744       —    

Other liabilities, excluding current installments

     10,982       6,795  

Deferred income tax liabilities

     19,364       15,363  
  

 

 

   

 

 

 

Total liabilities

     331,961       264,357  
  

 

 

   

 

 

 

Commitments and contingent liabilities

    

Stockholders’ equity:

    

Preferred stock, $.10 par value per share; authorized 400,000 shares; none issued

     —         —    

Common stock, $.10 par value per share; authorized 40,000,000 shares; issued 33,204,191 shares at June 30, 2019 and 32,752,827 shares at December 31, 2018

     3,321       3,276  

Additional paid-in capital

     85,614       83,177  

Accumulated other comprehensive loss

     (5,619     (4,507

Retained earnings

     268,692       262,840  
  

 

 

   

 

 

 
     352,008       344,786  

Less treasury stock at cost, 3,061,040 shares at June 30, 2019 and

2,902,992 shares at December 31, 2018

     (18,160     (15,556
  

 

 

   

 

 

 

Total stockholders’ equity

     333,848       329,230  
  

 

 

   

 

 

 

Total liabilities and stockholders’ equity

   $ 665,809     $ 593,587  
  

 

 

   

 

 

 


AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

(Unaudited)

 

     For the Three Months
Ended June 30,
     For the Six Months
Ended June 30,
 
     2019      2018      2019      2018  

Net sales

   $ 113,104      $ 107,046      $ 212,780      $ 211,154  

Cost of sales

     71,451        63,749        129,425        126,806  
  

 

 

    

 

 

    

 

 

    

 

 

 

Gross profit

     41,653        43,297        83,355        84,348  

Operating expenses

     35,362        34,718        70,162        68,418  
  

 

 

    

 

 

    

 

 

    

 

 

 

Operating income

     6,291        8,579        13,193        15,930  

Interest expense, net

     1,925        966        3,537        1,803  
  

 

 

    

 

 

    

 

 

    

 

 

 

Income before provision for income taxes and loss on equity method investments

     4,366        7,613        9,656        14,127  

Income tax expense

     1,224        1,748        2,584        3,440  
  

 

 

    

 

 

    

 

 

    

 

 

 

Income before loss on equity method investments

     3,142        5,865        7,072        10,687  

Loss from equity method investments

     36        301        60        518  
  

 

 

    

 

 

    

 

 

    

 

 

 

Net income

     3,106        5,564        7,012        10,169  

Net income attributable to non-controlling interest

     —          35        —          85  
  

 

 

    

 

 

    

 

 

    

 

 

 

Net income attributable to American Vanguard

   $ 3,106      $ 5,599      $ 7,012      $ 10,254  
  

 

 

    

 

 

    

 

 

    

 

 

 

Earnings per common share – basic

   $ .11      $ .19      $ .24      $ .35  
  

 

 

    

 

 

    

 

 

    

 

 

 

Earnings per common share – assuming dilution

   $ .11      $ .19      $ .24      $ .34  
  

 

 

    

 

 

    

 

 

    

 

 

 

Weighted average shares outstanding – basic

     29,001        29,330        28,989        29,309  
  

 

 

    

 

 

    

 

 

    

 

 

 

Weighted average shares outstanding – assuming dilution

     29,540        30,190        29,560        30,113  
  

 

 

    

 

 

    

 

 

    

 

 

 


AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

ANALYSIS OF SALES

For the three months and six months ended June 30, 2019 and 2018

(In thousands)

(Unaudited)

 

     For the three months
ended June 30,
              
     2019      2018      Change     % Change  

Net sales:

          

US crop

   $ 47,311      $ 51,760      $ (4,449     -9

US non-crop

     17,219        12,603        4,616       37
  

 

 

    

 

 

    

 

 

   

US total

     64,530        64,363        167       0

International

     48,574        42,683        5,891       14
  

 

 

    

 

 

    

 

 

   

Net sales:

   $ 113,104      $ 107,046      $ 6,058       6
  

 

 

    

 

 

    

 

 

   

Gross profit:

          

US crop

   $ 18,719      $ 26,222      $ (7,503     -29

US non-crop

     8,558        6,352        2,206       35
  

 

 

    

 

 

    

 

 

   

US total

     27,277        32,574        (5,297     -16

International

     14,376        10,723        3,653       34
  

 

 

    

 

 

    

 

 

   

Total gross profit:

   $ 41,653      $ 43,297      $ (1,644     -4
  

 

 

    

 

 

    

 

 

   

 

     For the six months
ended June 30,
              
     2019      2018      Change     % Change  

Net sales:

          

US crop

   $ 96,560      $ 108,785      $ (12,225     -11

US non-crop

     29,507        25,393        4,114       16
  

 

 

    

 

 

    

 

 

   

US total

     126,067        134,178        (8,111     -6

International

     86,713        76,976        9,737       13
  

 

 

    

 

 

    

 

 

   

Net sales:

   $ 212,780      $ 211,154      $ 1,626       1
  

 

 

    

 

 

    

 

 

   

Gross profit:

          

US crop

   $ 42,214      $ 50,753      $ (8,539     -17

US non-crop

     14,872        12,432        2,440       20
  

 

 

    

 

 

    

 

 

   

US total

     57,086        63,185        (6,099     -10

International

     26,269        21,163        5,106       24
  

 

 

    

 

 

    

 

 

   

Total gross profit:

   $ 83,355      $ 84,348      $ (993     -1
  

 

 

    

 

 

    

 

 

   


AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

 

     For the Six Months
Ended June 30,
 
     2019     2018  

Cash flows from operating activities:

    

Net income

   $ 7,012     $ 10,169  

Adjustments to reconcile net income to net cash provided by operating activities:

    

Depreciation and amortization of property, plant and equipment and intangible assets

     9,233       9,516  

Amortization of other long term assets

     2,146       2,313  

Amortization of discounted liabilities

     —         202  

Provision for bad debts

     445       181  

Revision of deferred compensation

     (2,888     (1,468

Stock-based compensation

     2,995       2,778  

Change in deferred income taxes

     (572     (26

Loss from equity method investments

     60       518  

Changes in assets and liabilities associated with operations:

    

Decrease in net receivables

     7,841       5,297  

Increase in inventories

     (27,635     (40,194

Increase in prepaid expenses and other assets

     (1,844     (707

Increase in net operating lease liability

     73       —    

Increase in income tax receivable/payable, net

     (4,480     (271

(Decrease) increase in accounts payable

     (10,138     11,309  

Decrease in deferred revenue

     (19,438     (7,254

Increase in accrued program costs

     11,823       15,039  

Decrease in other payables and accrued expenses

     (6,719     (3,683
  

 

 

   

 

 

 

Net cash (used in) provided by operating activities

     (32,086     3,719  
  

 

 

   

 

 

 

Cash flows from investing activities:

    

Capital expenditures

     (7,216     (3,230

Acquisition of business, product lines, and intangible assets

     (24,302     (1,631
  

 

 

   

 

 

 

Net cash used in investing activities

     (31,518     (4,861
  

 

 

   

 

 

 

Cash flows from financing activities:

    

Payments under line of credit agreement

     (54,200     (62,125

Borrowings under line of credit agreement

     122,000       58,800  

Net (payments) receipts from the issuance of common stock (sale of stock under ESPP, exercise of stock options, and shares purchased for tax withholding)

     (513     1,335  

Repurchase of common stock

     (2,604     —    

Payment of cash dividends

     (1,160     (1,024
  

 

 

   

 

 

 

Net cash provided by (used in) financing activities

     63,523       (3,014
  

 

 

   

 

 

 

Net decrease in cash and cash equivalents

     (81     (4,156

Effect of exchange rate changes on cash and cash equivalents

     220       (82

Cash and cash equivalents at beginning of period

     6,168       11,337  
  

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 6,307     $ 7,099  
  

 

 

   

 

 

 


AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

UNAUDITED RECONCILIATION OF NET INCOME TO EBITDA

For the three months and six months ended June 30, 2019 and 2018

(Unaudited)

 

     Three Months Ended
June 30,
     Six Months Ended
June 30,
 
     2019      2018      2019      2018  

Net income attributable to American Vanguard, as reported

   $ 3,106      $ 5,599      $ 7,012      $ 10,254  

Provision for income taxes

     1,224        1,748        2,584        3,440  

Interest expense, net

     1,925        966        3,537        1,803  

Depreciation and amortization

     5,688        5,683        11,379        11,829  
  

 

 

    

 

 

    

 

 

    

 

 

 

EBITDA2

   $ 11,943      $ 13,996      $ 24,512      $ 27,326  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

2 

Earnings before interest, taxes, depreciation and amortization. EBITDA is not a financial measure calculated and presented in accordance with U.S. generally accepted accounting principles (GAAP) and should not be considered as an alternative to net income (loss), operating income (loss) or any other financial measures so calculated and presented, nor as an alternative to cash flow from operating activities as a measure of liquidity. The items excluded from EBITDA are detailed in the reconciliation attached to this news release. Other companies (including the Company’s competitors) may define EBITDA differently.